502 related articles for article (PubMed ID: 24720436)
1. Combining bioinformatics and MS-based proteomics: clinical implications.
Acosta-Martin AE; Lane L
Expert Rev Proteomics; 2014 Jun; 11(3):269-84. PubMed ID: 24720436
[TBL] [Abstract][Full Text] [Related]
2. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
3. Qupe--a Rich Internet Application to take a step forward in the analysis of mass spectrometry-based quantitative proteomics experiments.
Albaum SP; Neuweger H; Fränzel B; Lange S; Mertens D; Trötschel C; Wolters D; Kalinowski J; Nattkemper TW; Goesmann A
Bioinformatics; 2009 Dec; 25(23):3128-34. PubMed ID: 19808875
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics challenges in mass spectrometry-driven proteomics.
Martens L
Methods Mol Biol; 2011; 753():359-71. PubMed ID: 21604135
[TBL] [Abstract][Full Text] [Related]
5. Analysis of mass spectrometry data in proteomics.
Matthiesen R; Jensen ON
Methods Mol Biol; 2008; 453():105-22. PubMed ID: 18712299
[TBL] [Abstract][Full Text] [Related]
6. Mass Spectrometry-Based Protein Quantification.
Chen Y; Wang F; Xu F; Yang T
Adv Exp Med Biol; 2016; 919():255-279. PubMed ID: 27975224
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins.
Boja ES; Rodriguez H
Proteomics; 2012 Apr; 12(8):1093-110. PubMed ID: 22577011
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics.
Thomas A; Lenglet S; Chaurand P; Deglon J; Mangin P; Mach F; Steffens S; Wolfender JL; Staub C
Thromb Haemost; 2011 Jul; 106(1):20-33. PubMed ID: 21614412
[TBL] [Abstract][Full Text] [Related]
9. Industrialized MS-based proteomics in the search for circulating biomarkers.
Migneault I; Hunter JM
Bioanalysis; 2009 Sep; 1(6):1149-63. PubMed ID: 21083081
[TBL] [Abstract][Full Text] [Related]
10. CE-MS in biomarker discovery, validation, and clinical application.
Mischak H; Schanstra JP
Proteomics Clin Appl; 2011 Feb; 5(1-2):9-23. PubMed ID: 21280234
[TBL] [Abstract][Full Text] [Related]
11. Expanding the organismal scope of proteomics: cross-species protein identification by mass spectrometry and its implications.
Liska AJ; Shevchenko A
Proteomics; 2003 Jan; 3(1):19-28. PubMed ID: 12548630
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics tools to identify and quantify proteins using mass spectrometry data.
Ryu SY
Adv Protein Chem Struct Biol; 2014; 94():1-17. PubMed ID: 24629183
[TBL] [Abstract][Full Text] [Related]
13. In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry.
Elschenbroich S; Ignatchenko V; Clarke B; Kalloger SE; Boutros PC; Gramolini AO; Shaw P; Jurisica I; Kislinger T
J Proteome Res; 2011 May; 10(5):2286-99. PubMed ID: 21491939
[TBL] [Abstract][Full Text] [Related]
14. Alignment of LC-MS images, with applications to biomarker discovery and protein identification.
Vandenbogaert M; Li-Thiao-Té S; Kaltenbach HM; Zhang R; Aittokallio T; Schwikowski B
Proteomics; 2008 Feb; 8(4):650-72. PubMed ID: 18297649
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in computational analysis of mass spectrometry for proteomic profiling.
Sun CS; Markey MK
J Mass Spectrom; 2011 May; 46(5):443-56. PubMed ID: 21500303
[TBL] [Abstract][Full Text] [Related]
16. MSDA, a proteomics software suite for in-depth Mass Spectrometry Data Analysis using grid computing.
Carapito C; Burel A; Guterl P; Walter A; Varrier F; Bertile F; Van Dorsselaer A
Proteomics; 2014 May; 14(9):1014-9. PubMed ID: 24677806
[TBL] [Abstract][Full Text] [Related]
17. Protein mass spectra data analysis for clinical biomarker discovery: a global review.
Roy P; Truntzer C; Maucort-Boulch D; Jouve T; Molinari N
Brief Bioinform; 2011 Mar; 12(2):176-86. PubMed ID: 20534688
[TBL] [Abstract][Full Text] [Related]
18. Application of LC/MS to proteomics studies: current status and future prospects.
Chen G; Pramanik BN
Drug Discov Today; 2009 May; 14(9-10):465-71. PubMed ID: 19429505
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometry-based clinical proteomics.
Pusch W; Flocco MT; Leung SM; Thiele H; Kostrzewa M
Pharmacogenomics; 2003 Jul; 4(4):463-76. PubMed ID: 12831324
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in clinical proteomics using mass spectrometry.
Dowling P; Meleady P; Henry M; Clynes M
Bioanalysis; 2010 Sep; 2(9):1609-15. PubMed ID: 21083289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
